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Polybrominated diphenyl ethers (PBDEs) are 
a class of brominated flame retardants (BFRs) 
used to reduce the flammability of a multitude 
of products, including electrical and electronic 
equipment, plastics, textiles, and furniture. 
PBDEs are additive chemicals that can leach 
from products over time and have a tendency 
to bioaccumulate and bioconcentrate (Martin 
et al. 2004; McDonald 2002). Their use over 
the last 30 years has resulted in worldwide con-
tamination of biological and environmental 
samples (Hites 2004).
Data on adverse health effects due to 
human exposure to PBDEs are limited. Recent 
studies, however, have shown PBDE concen-
trations in human milk to be associated with 
congenital cryptorchidism (Main et al. 2007) 
or with lower birth weight, length, and chest 
circumference (Chao et al. 2007). Thyroid 
hormone homeostasis in children may be dis-
rupted because of exposure to PBDEs and 
other contaminants via house dust (Suzuki 
et al. 2007). Developmental, reproductive, 
and neurotoxic effects, as well as permanent 
effects on learning, activity, and behaviors 
after PBDE exposure have been reported in 
animals (Birnbaum 2007), with reproduc-
tive and developmental toxicity studies show-
ing that fetuses are more sensitive to PBDEs 
than are adults (Darnerud et al. 2001). Costa 
and Giordano (2007) state that there is 
accumulating evidence showing that PBDE 
exposure in animals causes developmental 
neurotoxicity at doses similar to those reported 
in the North American human population.
Data suggest that human exposure to 
PBDEs occurs in a variety of ways: dietary 
sources (e.g., Darnerud et al. 2006; Domingo 
et al. 2008), inhalation in indoor and outdoor 
environments as well as in cars (e.g., Allen 
et al. 2007; Mandalakis et al. 2008; Wilford 
et al. 2005), and dust ingestion (e.g., Sjödin 
et al. 2008a; Stapleton et al. 2005). Infants and 
young children receive additional exposure via 
placental transfer (Bi et al. 2006; Gomara et al. 
2007; Mazdai et al. 2003; Schecter et al. 2007), 
consumption of human milk (Carrizo et al. 
2007), and child-specific behaviors, including 
mouthing of hands and objects possibly con-
taminated with PBDEs (Stapleton et al. 2008).
PBDEs have been detected in human 
blood of adults from many countries (e.g., 
Gomara et al. 2007; Harrad and Porter 2007; 
Lee et al. 2007; Sandanger et al. 2007; Sjödin 
et al. 2008b). However, despite the limited 
scientific evidence suggesting PBDE concen-
trations in young children are elevated com-
pared with adults (Fischer et al. 2006; Sjödin 
et al. 2008b; Thomsen et al. 2002), few stud-
ies have focused on PBDE concentrations in 
infants and children. Previously, we observed 
PBDE concentrations in children 0–4 years of 
age in Australia to be four to five times higher 
than concentrations in adults > 16 years of age 
(Toms et al. 2008), although the use of wide 
age brackets for pooled samples resulted in an 
inability to accurately assess the age at which 
the levels peaked.
The aim of this study was to investigate the 
age and level of peak PBDE concentrations in 
the Australian population, with an emphasis 
on infants and children. Human blood samples 
were collected from 17 age groups [ranging 
from newborn (cord blood) to > 60 years] to 
assess PBDE concentrations. From newborn 
to 4 years of age, the age brackets covered 
6-month periods, followed by 3-year periods for 
ages 4–15 years and 15-year periods for ages 16 
to > 60 years. In addition to samples from chil-
dren, we collected adult samples in 2006–2007 
for temporal comparison with data collected in 
Australia in 2002–2003 and 2004–2005.
Materials and Methods
Samples. We obtained deidentified serum 
samples from Sullivan Nicolaides Pathology 
(Taringa, Queensland, Australia) from surplus 
stored sera that had been collected as part of 
routine pathology testing. All samples were col-
lected from South East Queensland because 
previous studies found no geographic differences 
among pooled samples collected from different 
regions of Australia (Toms et al. 2008). Before 
pooling, we stratified all samples according to 
age and sex. The age groups were as follows: 
newborn (cord blood), 0–0.5, 0.6–1, 1.1–1.5, 
1.6–2, 2.1–2.5, 2.6–3, 3.1–3.5, 3.6–4, 4.1–6, 
6.1–9, 9.1–12, 12.1–15, 16–30, 31–45, 46–60, 
and > 60 years. Age, sex, and date of collection 
were available for each sample. We calculated 
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Ba c k g r o u n d: Polybrominated diphenyl ethers (PBDEs) are used as flame retardants in many 
products and have been detected in human samples worldwide. Limited data show that concentra-
tions are elevated in young children.
oBjectives: We investigated the association between PBDEs and age with an emphasis on young 
children from Australia in 2006–2007.
Me t h o d s : We collected human blood serum samples (n = 2,420), which we stratified by age and 
sex and pooled for analysis of PBDEs.
re s u l t s: The sum of BDE-47, -99, -100, and -153 concentrations (Σ4PBDE) increased from 0–0.5 
years (mean ± SD, 14 ± 3.4 ng/g lipid) to peak at 2.6–3 years (51 ± 36 ng/g lipid; p < 0.001) and 
then decreased until 31–45 years (9.9 ± 1.6 ng/g lipid). We observed no further significant decrease 
among ages 31–45, 45–60 (p = 0.964), or > 60 years (p = 0.894). The mean Σ4PBDE concentration 
in cord blood (24 ± 14 ng/g lipid) did not differ significantly from that in adult serum at ages 15–30 
(p = 0.198) or 31–45 years (p = 0.140). We found no temporal trend when we compared the present 
results with Australian PBDE data from 2002–2005. PBDE concentrations were higher in males 
than in females; however, this difference reached statistical significance only for BDE-153 (p = 0.05).
co n c l u s i o n s: The observed peak concentration at 2.6–3 years of age is later than the period when 
breast-feeding is typically ceased. This suggests that in addition to the exposure via human milk, 
young children have higher exposure to these chemicals and/or a lower capacity to eliminate them.
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the mean age of the pool by taking the mean 
of all ages of donors included in the pool. This 
study aimed to investigate PBDE concentration 
in infants and children, so we used small age 
ranges for younger age groups and larger age 
ranges for older age groups where changes in 
PBDE concentration were previously shown to 
be less apparent (Toms et al. 2008).
The aim of the sample collection was to 
combine up to 30 samples per pool with rep-
licate pools per strata where sufficient samples 
existed [see Supplemental Material, Table 1 
(doi:10.1289/ehp.0900596.S1 via http://
dx.doi.org)]. Where possible, we used 1 mL of 
serum from each sample. Because of the small 
volume of blood obtained from infants and 
young children, we used < 1 mL in some pools, 
although we combined the same sample vol-
ume from each donor to form a specific pool. 
We collected a total of 2,420 individual samples 
and combined them into 84 pools. We used 
disposable polyurethane pipettes to draw the 
sample from polypropylene tubes in which the 
serum was stored. The sample was placed into 
a 50-mL glass jar and 10 mL was aliquoted into 
an amber jar for transport to the laboratory.
We used pooled samples because it is the 
most effective way to obtain large numbers of 
blood samples from the specific age groups. 
Difficulties in obtaining parental consent and 
cooperation of children for blood draws pre-
cluded the use of individual samples, as did 
the volume required for PBDE analysis, which 
we would have been unlikely to obtain in one 
blood draw from an infant or young child. 
Ethics approval was granted on 28 June 2006 
by the University of Queensland Medical 
Research Ethics Committee. The analysis of 
pooled samples by investigators at the U.S. 
Centers for Disease Control and Prevention 
(CDC) was determined not to constitute 
engagement in human subjects research. 
Analysis. The samples were analyzed at the 
CDC (Atlanta, GA, USA) with method  ology 
that has been described previously (Sjödin 
et al. 2004b). Briefly, a set of samples was 
defined as 24 unknown samples with three 
analytical blanks and three quality assurance/
quality control samples and processed using a 
semiautomated sample preparation method. 
Human sera (2 g) were weighed into test 
tubes and fortified with internal standards 
(13C-labeled) using a 215 Liquid Handler 
(Gilson Inc., Middleton, WI, USA). Then for-
mic acid and water were added to denature 
proteins and dilute the samples on the liquid 
handler. The target analytes were extracted 
into dichloromethane using the solid-phase 
extraction (SPE) workstation (Rapid Trace; 
Zymark, Hopkinton, MA, USA). Cleanup 
was performed on a two-layered column. The 
top layer comprised activated silica and the 
bottom layer comprised silica gel/sulfuric acid 
(2:1 by weight). The top layer retained polar 
lipids such as cholesterol, whereas the bottom 
layer degraded the remaining lipids to produce 
an extract free of biogenic material. This pro-
cedure was automated using the modular SPE 
workstation. Samples were evaporated to 1 mL 
and transferred to the gas chromatograph vials, 
which were previously spiked with recovery 
standards. Samples were further evaporated to 
10 µL and analyzed by gas chromatography/ 
high-resolution mass spectrometry with a 
MAT95XP instrument (ThermoFinnigan, 
Bremen, Germany). Chromatographic separa-
tions were carried out on a 6890 gas chromato-
graph (Agilent Technologies, Atlanta, GA, 
USA) fitted with a DB5HT capillary column 
(15 m, 0.25 mm inner diameter, and 0.10 µm 
thickness). The following congeners were tar-
geted for analysis: BDE-17, -28, -47, -66, 
-85, -99, -100, -153, -154, and -183. BDE-
209 was not assessed in these samples because 
the analytical methodology for this congener 
was not yet fully established. The results are 
expressed as nanograms per gram of lipid and 
are reported to two significant figures, using a 
value of zero for congeners with concentrations 
below the limit of detection (LOD), which 
depended on sample size and blanks. Σ4PBDE 
concentrations are the sum of BDE-47, -99, 
-100, and -153.
Quality control/quality assurance. To assess 
the reproducibility of the sampling procedures, 
we analyzed replicate samples collected in the 
same strata and compared them. In addition, 
we included two blind field blanks, which com-
prised of bovine serum (Sigma Aldrich B8655; 
Sigma Aldrich, St. Louis, MO, USA) expected 
to have a PBDE concentration below the LOD 
with the analytical methodology used. In these 
blanks, only one congener was present at a con-
centration slightly above the instrumental LOD, 
indicating low or negligible contamination 
during the sample collection and pooling. The 
congener that was detected in one sample was 
BDE-99, found at a concentration of 2.9 pg/g 
serum with an LOD of 2.6 pg/g serum.
Statistical analysis. Statistical analysis was 
mostly descriptive, with average concentra-
tions (means or medians) and SDs or ranges 
reported overall and within age, sex, and collec-
tion date groups. We fitted analysis of variance 
(ANOVA) models (including age group, sex, 
collection date, and their interaction effects) 
to test the hypothesis that concentrations dif-
fered by overall age group, overall sex, or over-
all collection date or to test whether age group 
differences were sex specific. The age groups 
used in this analysis were as described above, 
(“Samples”). We used the conventional p-value 
of 5% to report results as statistically significant. 
We did not include BDE-17, -28, -66, -85, 
-154, or -183, which were detected in < 60% of 
samples, in the statistical analysis. We performed 
statistical analysis using SPSS version 16.0 for 
Windows (SPSS Inc., Chicago, IL, USA).
Results and Discussion
We detected PBDEs in all 84 pools of human 
blood serum; the Σ4PBDE concentration 
ranged from 5.5 to 103 ng/g lipid. Overall, 
concentrations in children were higher than 
in adults and varied by age. For adults (both 
sexes) > 16 years of age, the mean ± SD of 
Σ4PBDEs was 16 ± 18 ng/g lipid. We detected 
BDE-47, -99, -100, and -153 in all samples, 
whereas we detected BDE-183, -154, and -85 
in 43%, 25%, and 21% of samples, respec-
tively. The concentrations of BDE-47, -99, 
-100, and -153 across both sexes and all age 
groups were 2.6–55.1, 0.9–24.2, 0.6–14.1, 
and 1.3–13.7 ng/g lipid, respectively [for full 
details, see Supplemental Material, Tables 1 
and 2 (doi:10.1289/ehp.0900596.S1)].
We determined the coefficient of varia-
tion (CV) using the results within each stra-
tum to compare the reproducibility of sampling 
procedures between pools. For 70% of strata, 
the CV between replicates was < 35%. The 
mean (range) CV was 34% (0.3–103%), 30% 
(0–100%), 29% (1–106%), and 26% (3–83%) 
for BDE-47, -99, -100, and -153, respectively. 
Although variability between replicate pools 
was evident in some strata, most showed good 
agreement, indicating that sample collection 
and pooling procedures were uniform, and it 
is unlikely that contamination of the samples 
occurred during sampling. High variability 
between individuals has been reported previ-
ously (Birnbaum and Cohen Hubal 2006; Ryan 
et al. 2002; Schecter et al. 2003), and variability 
between replicates is likely attributable to the 
inclusion in these pools of a few serum samples 
with an elevated concentration. The distribution 
of individual results in this study is unknown 
because only pools have been measured; how-
ever, in a U.S. cohort of 2,060 individual serum 
samples, the reported median concentration of 
BDE-47 was 19.2 ng/g lipid, with a maximum 
concentration of 2,350 ng/g lipid (Sjödin et al. 
2008b). These levels far exceed the median and 
would thus have caused the elevated level in a 
few of the serum pools as observed. Individual 
variability and a lack of exposure data are limi-
tations of using pooled samples.
Age. For children, mean Σ4PBDE concen-
trations were highest in the 2- to 5-year age 
groups, with the maximum Σ4PBDE concentra-
tion (103 ng/g lipid) detected in a pool of serum 
from females 2.6–3 years of age (Figure 1). We 
summarized samples into broader age brack-
ets and ran an ANOVA with post hoc Tukey 
test. The mean Σ4PBDE concentrations from 
cord blood samples and samples from ages 0–2, 
6–12, and 13–30 years were similar to each 
other but were significantly different from con-
centrations detected in children in the 2- to 
5-year age group (Table 1). We observed the 
lowest concentrations in the adults > 31 years 
of age, which were also significantly differ-
ent from those in the 2- to 5-year age group. PBDEs concentrations are high in children
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We detected the lowest Σ4PBDE concentra-
tion (5.5 ng/g lipid) in a pool from females 
> 60 years of age. Σ4PBDE concentrations in 
three pools of cord blood ranged from 14 to 
40 ng/g lipid, with a mean of 24 ng/g lipid, 
similar to those in females 15–45 years of age, 
whose levels ranged from 8.1 to 77 ng/g lipid, 
with a mean of 27 ng/g lipid. The cord and 
female blood samples compared here were not 
fetus–mother pairs, and comparisons should be 
made with caution because both correlated (Bi 
et al. 2006; Mazdai et al. 2003) and noncorre-
lated (Gomara et al. 2007; Meironyté Guvenius 
et al. 2003) PBDE concentrations in paired 
cord–maternal blood have been reported.
The results of the present study confirm 
our previous findings of elevated PBDE con-
centrations in children 0–4 years of age relative 
to adults > 16 years of age (Toms et al. 2008). 
Higher PBDE concentrations in children have 
been reported in a limited number of studies 
(Environmental Working Group 2008; Fischer 
et al. 2006; Thomsen et al. 2002). In contrast, 
another study found no difference in PBDE 
concentrations between mothers and their chil-
dren 7 years of age (Fängström et al. 2005). 
The present study, however, is the first to use 
6-month age brackets for samples ranging in 
age from newborn (cord blood) to 4-year-olds 
to determine at what age PBDEs concentra-
tions peak. Increased PBDE concentrations in 
neonates and infants is most likely attributable 
to placental transfer and the consumption of 
human milk (e.g., Noren and Meironyté 2000; 
Schecter et al. 2003; Toms et al. 2007), with 
PBDE concentrations in sera of 4-year-olds 
reportedly higher in breast-fed children than 
in formula-fed children (Carrizo et al. 2007). 
In Australia, breast-feeding rates decrease 
from 85% at birth to 45% at 6 months, 
23% at 12 months, and 1% at 24 months 
(Australian Bureau of Statistics 2003); con-
sequently, for most infants, exposure via this 
pathway would not typically persist after the 
first year of life. Despite this pattern, PBDE 
concentrations appear to increase past 1 year 
of age. Interestingly, an increasing age trend 
was not apparent for polychlorinated biphenyls 
and persistent pesticides in these same samples 
from birth to 15 years of age (data not shown), 
indicating that the routes of exposure are dif-
ferent for PBDEs than for traditional persis-
tent organic pollutants. However, we found an 
increasing trend for polychlorinated biphenyls 
and persistent pesticides with the subjects’ age 
for older subjects (data not shown).
We have previously used modeled data, 
taking into consideration intake and half-
lives, to predict the trend of elevated con-
centrations in Australian infants and young 
children, but we did not find the magni-
tude or age of peak PBDE concentrations 
that we found in the present study (Toms 
et al. 2008). Reasons for this underestimation 
may be related to the half-life values used, 
which may be inaccurate for children, and 
missing PBDE sources that may contribute 
to intake levels during early years. The half-
lives of PBDEs have been calculated as 1.8, 
2.9, 1.6, and 6.5 years for BDE-47, -99, 
-100, and -153, respectively (Geyer et al. 
2004) for non-occupationally exposed adult 
humans and are based on daily intake and 
total body burden data. Dust has been sug-
gested as a major source of PBDEs in young 
children (Jones-Otazo et al. 2005; Lorber 
2008; Stapleton et al. 2005), with intake of 
BDE-47 via dust in Australian 2.5-year-olds 
estimated at 1–140 ng/day (assuming a daily 
dust intake rate of 50–100 mg) (Sjödin et al. 
2008a). Food intake of tetra-BDEs, of which 
BDE-47 is the major congener, is estimated at 
21 ng/day for this age group (Food Standards 
Australia and New Zealand 2007). However, 
variability in dust intake estimates (U.S. 
Environmental Protection Agency 1997) 
renders calculation of PBDE intake via this 
pathway less certain. In addition, BFRs have 
been detected in baby products such as car 
seats (Gearhart et al. 2007) and may result 
in exposures specific to young children. The 
pathways and level of exposure from such 
sources require further investigation.
Similar to previous reports (Bradman 
et al. 2007; Gomara et al. 2007; Harrad and 
Porter 2007; Julander et al. 2005; Lee et al. 
2007), we observed no apparent change in 
adult PBDE concentration with age.
Sex. For all age groups combined, the 
mean ± SD Σ4PBDE concentrations in males 
was 26 ± 13 ng/g lipid and in females was 
28 ± 20 ng/g lipid. For adults > 16 years of 
age, the mean ± SD Σ4PBDE concentration for 
males was 15 ± 11 ng/g lipid and for females 
was 18 ± 24 ng/g lipid. This sex difference was 
statistically significant (p = 0.05) for BDE-153 
only. Higher PBDE concentrations in males 
than in females have been reported previously 
(Meneses et al. 1999; Schroter-Kermani et al. 
2000; Takasuga et al. 2004; Thomsen et al. 
2002) and appears to be attributable to placen-
tal transfer and elimination during lactation. In 
contrast, other studies have reported either no 
difference or higher concentrations in females 
(Gomara et al. 2007; Schecter et al. 2005).
Congener profile. The congener profile 
in all samples was dominated by BDE-47 
(mean, 47%; range of contribution to 
Σ4PBDEs, 31–61%), followed by BDE-153 
(20%; 7–47%), BDE-99 (17%; 10–33%), 
and BDE-100 (13%; 10–18%), whereas the 
remaining BDE congeners contributed < 10% 
to total PBDEs. Overall, the profile in these 
samples was similar to those found in stud-
ies of human blood from Australia, New 
Zealand, North America, and Europe (Harrad 
and Porter 2007; Schecter et al. 2005; Sjödin 
et al. 2004a; Thomsen et al. 2002; Toms et al. 
2008). In cord blood, the profile was also dom-
inated by BDE-47, followed by BDE-99, -153, 
and -100, which is consistent with findings by 
Gomara et al. (2007). However, others have 
found BDE-153 in higher concentrations than 
BDE-99 (Bi et al. 2006; Meironyté Guvenius 
et al. 2003).
We found no observable differences in pro-
file by sex, except for BDE-153, which made 
a greater contribution to the Σ4PBDE con-
centration in males than in females. The lev-
els of congener contribution to the Σ4PBDE 
Table 1. Mean (95% confidence interval) Σ4PBDE 
(BDE-47, -99, -100, and -153) concentrations (ng/g 
lipid) by age (years), including outliers, for 2006–2007.
Age (years)
Mean Σ4PBDE  
concentration  
(95% CI)
Comparison 
with 2- to 
5-year age 
group (p-value)
Newborn (cord blood) 24 (–11 to 59)a 0.047* 
  0–2 31 (24 to 38) 0.026* 
  2–6 41 (33 to 49) —
  7–12 26 (20 to 31) 0.002* 
  13–30 20 (12 to 28) < 0.001* 
  > 31 9.4 (7.9 to 11) < 0.001* 
aThree pools only. *p < 0.05.
Figure 1. Σ4PBDE concentrations (ng/g lipid) by mean age (0–80 years) and sex. Each point represents a 
pool of up to 30 individual blood samples.
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concentration changed with age (Figure 2). The 
contributions of BDE-47 and -99 decreased 
with age until around 8 years of age, whereas 
BDE-100 and -153 increased with age until 
5 and 14 years of age, respectively. The half-
life of BDE-47 is reportedly shorter than that 
of BDE-153 (1.8 vs. 6.5 years; Geyer et al. 
2004), which may explain the differences in 
the congener contribution with age. In addi-
tion, higher brominated diphenyl ethers are 
reported to pass the placenta at lower rates 
compared with lower brominated diphenyl 
ethers (Bi et al. 2006; Meironyté Guvenius 
et al. 2003; Schecter et al. 2007), and this may 
explain why BDE-153 is found in lower con-
centrations in the younger age groups. Qiu 
et al. (2009) noted that BDE-99 was more 
likely to be hydroxylated than are BDE-47 and 
BDE-100 in humans, which may explain why 
concentrations of BDE-99 decrease from birth 
compared with BDE-47 and -100.
Australian comparison. We compared 
PBDE concentrations found in this study 
with those from adult samples collected 
and pooled in Australia in 2002–2003 and 
2004–2005 [Supplemental Material, Figure 1 
(doi:10.1289/ehp.0900596.S1)]. Because 
the age brackets for the younger age groups 
were different in the two collection peri-
ods, we compared samples only from adults 
> 16 years of age. We found no difference in 
mean Σ4PBDE concentrations for male and 
female adults > 16 years of age among samples 
from 2002–2003 (9.9 ± 4.1 ng/g lipid), 2004–
2005 (8.1 ± 2.2 ng/g lipid), and 2006–2007 
(9.9 ± 2.6 ng/g lipid). Notably, this value for   
2006–2007 excluded two elevated results; 
when we included these, the 2006–2007 mean 
concentration was 16 ± 19 ng/g lipid. This 
indicates that despite a ban on the production 
of penta- and octa-BDE technical products in 
the European Union in 2004, a phase-out of 
manufacture of these products in the United 
States in 2004, and no imports or manufac-
turing of these pure products in Australia 
since 2005 (National Industrial Chemicals 
Notification and Assessment Scheme 2007), 
the Australian PBDE human body burden has 
not yet significantly decreased. This is most 
likely attributable to continued import of 
products treated with PBDEs, the longevity of 
products treated with PBDEs (e.g., electrical 
and electronic equipment, furniture, textiles), 
and possible exposure after the disposal of 
these products (Kim et al. 2006). Another fac-
tor that may have influenced these findings is 
the use of different analytical methods for the 
2002–2003 and 2004–2005 samples [which 
were analyzed at Eurofins ERGO GmbH 
(Hamburg, Germany), as described previously] 
(Toms et al. 2008), versus the 2006–2007 
samples, which were analyzed at the CDC. 
However, it should be noted that both the 
laboratories CDC and Eurofins ERGO par-
ticipate regularly in intercalibration programs 
in order to certify the analytical measure-
ments [see Supplemental Material for details 
(doi:10.1289/ehp.0900596.S1)].
International comparison. International 
pediatric PBDE data are limited. Where pos-
sible, we matched comparisons of data from 
other countries to age groups in the present 
study. Because of different reporting practices 
for sum concentrations, we compared only 
BDE-47 concentrations. Overall, Australian 
BDE-47 concentrations in young children 
were higher than those in European countries 
but lower than those in the United States.
The mean BDE-47 concentration in 
Australian children 0–4 years of age was 
19 ng/g lipid, which is three times higher 
than results from a pooled Norwegian sam-
ple (n = 14; age 0–4 years), in which BDE-47 
was detected at 6.2 ng/g lipid (Thomsen et al. 
2002). A Menorca Island study found mean 
BDE-47 concentrations in breast-fed (n = 202) 
and formula-fed 4-year-old subjects (n = 42) 
to be 3.4 and 0.73 ng/g lipid, respectively, 
whereas the concentration from Australian chil-
dren was 5–20 times greater, at 16 ng/g lipid 
(Carrizo et al. 2007). Similar results were found 
when comparing data from 7-year-old children 
(n = 42) in the Faroe Islands, whose median 
BDE-47 concentrations were 0.87 ng/g lipid 
compared with approximately 15 times greater 
concentration for Australian children at 13 ng/g 
lipid (Fängström et al. 2005). Individual results 
obtained in 2004 in California (USA) from 
one 18-month-old toddler and a 5-year-old 
girl showed BDE-47 concentrations of 245 
and 137 ng/g lipid, respectively (Fischer et al. 
2006), whereas data from comparative age 
brackets in Australia were 21 ng/g lipid for 
1–2 year olds and 20 ng/g lipid for 4–6 year 
olds. Another study from the United States 
of 20 children ranging in age from 1.5 to 
4 years found a median BDE-47 concentration 
of 30.6 ng/g lipid (Environmental Working 
Group 2008), which is higher than that found 
in Australian children of this age (21 ng/g lipid) 
but lower than those detected in the California 
samples (Fischer et al. 2006). For older chil-
dren, the mean BDE-47 concentrations in 
Australian children 6–11 years of age ranged 
from 7.0 to 24 ng/g lipid for males and from 
5.1 to 14 ng/g lipid for females and were four 
to eight times lower than those collected from 
Mexican-American, non-Hispanic black, and 
non-Hispanic white children 6–11 years of 
age in 2001–2002 in the United States, whose 
BDE-47 concentrations ranged from around 
60 to 105 ng/g lipid for males and from 65 to 
110 ng/g lipid for females (Sjödin A, personal 
communication). PBDEs have been detected 
previously in cord blood from other countries. 
In the present study, the mean Σ4PBDE and 
BDE-47 concentrations in cord blood were 
24 ng/g lipid and 12 ng/g lipid, respectively, 
which is almost 10 times that found in China 
(Bi et al. 2006) and Sweden (Meironyté 
Guvenius et al. 2003), around twice that found 
in Spain (Gomara et al. 2007), but half the 
concentration reported from Indiana (USA) 
(Mazdai et al. 2003).
The mean BDE-47 concentrations in 
Australian adults were higher than those PBDE 
concentrations in human blood reported from 
New Zealand, Europe, the United Kingdom, 
and Asia (e.g., Bi et al. 2006; Harrad and 
Porter 2007; Schroter-Kermani et al. 2000; 
Thomas et al. 2006; Thomsen et al. 2002) 
but lower than those from samples from 
the United States (Anderson et al. 2008; 
Sandanger et al. 2007; Schecter et al. 2005; 
Figure 2. Contribution of BDE-47 and -153 (A) and BDE-99 and -100 (B) to the Σ4PBDE concentration by age (note difference of scale on y-axis).
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Sjödin et al. 2008b). However, because of dif-
ferent study designs, analytical techniques, and 
included congeners, any comparisons should 
be made with caution.
In conclusion, the determination of 
PBDEs in human blood sera pooled using 
6-month age brackets for samples from new-
borns (cord blood) through to 4-year-olds 
revealed higher PBDE concentrations in 
young children compared with infants and 
adults. To identify the causes of these elevated 
concentrations, exposure studies should focus 
on these younger age groups, and an investiga-
tion into potential differences in the half-lives 
of these chemicals in children compared with 
adults is necessary.
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